Artelo Biosciences ARTL Stock
Artelo Biosciences Price Chart
Artelo Biosciences ARTL Financial and Trading Overview
| Artelo Biosciences stock price | 1.23 USD |
| Previous Close | 1.26 USD |
| Open | 1.24 USD |
| Bid | 0.89 USD x 200 |
| Ask | 1.58 USD x 200 |
| Day's Range | 1.23 - 1.27 USD |
| 52 Week Range | 1.19 - 85.8 USD |
| Volume | 104.35K USD |
| Avg. Volume | 3.26M USD |
| Market Cap | 4.29M USD |
| Beta (5Y Monthly) | -0.137 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -29.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ARTL Valuation Measures
| Enterprise Value | -6683746 USD |
| Trailing P/E | N/A |
| Forward P/E | -1.3977273 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.1615021 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Artelo Biosciences Stock Price History
| Beta (5Y Monthly) | -0.137 |
| 52-Week Change | -92.95% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 85.8 USD |
| 52 Week Low | 1.19 USD |
| 50-Day Moving Average | 2.57 USD |
| 200-Day Moving Average | 6.26 USD |
ARTL Share Statistics
| Avg. Volume (3 month) | 3.26M USD |
| Avg. Daily Volume (10-Days) | 243.19K USD |
| Shares Outstanding | 3.49M |
| Float | 2.17M |
| Short Ratio | 0.08 |
| % Held by Insiders | 2.47% |
| % Held by Institutions | 8.09% |
| Shares Short | 218.9K |
| Short % of Float | 6.28% |
| Short % of Shares Outstanding | 6.28% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -91.32% |
| Return on Equity (ttm) | -367.69% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -13465000 USD |
| Diluted EPS (ttm) | -29.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.27M USD |
| Total Cash Per Share (mrq) | 4.4 USD |
| Total Debt (mrq) | 719K USD |
| Total Debt/Equity (mrq) | 10.78 USD |
| Current Ratio (mrq) | 1.788 |
| Book Value Per Share (mrq) | 7.616 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8114000 USD |
| Levered Free Cash Flow (ttm) | -3082625 USD |
Profile of Artelo Biosciences
| Country | United States |
| State | CA |
| City | Solana Beach |
| Address | 505 Lomas Santa Fe |
| ZIP | 92075 |
| Phone | 858 925 7049 |
| Website | https://artelobio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 7 |
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications. It also offers ART26.12, a fatty acid binding protein 5 inhibitor for treating chemotherapy induced peripheral neuropathy, diabetic neuropathy, prostate cancer and breast cancer, pain, dermatologic conditions, and anxiety disorders. The company was formerly known as Reactive Medical Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was incorporated in 2011 and is based in Solana Beach, California.
Q&A For Artelo Biosciences Stock
What is a current ARTL stock price?
Artelo Biosciences ARTL stock price today per share is 1.23 USD.
How to purchase Artelo Biosciences stock?
You can buy ARTL shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Artelo Biosciences?
The stock symbol or ticker of Artelo Biosciences is ARTL.
Which industry does the Artelo Biosciences company belong to?
The Artelo Biosciences industry is Biotechnology.
How many shares does Artelo Biosciences have in circulation?
The max supply of Artelo Biosciences shares is 3.49M.
What is Artelo Biosciences Price to Earnings Ratio (PE Ratio)?
Artelo Biosciences PE Ratio is now.
What was Artelo Biosciences earnings per share over the trailing 12 months (TTM)?
Artelo Biosciences EPS is -29.01 USD over the trailing 12 months.
Which sector does the Artelo Biosciences company belong to?
The Artelo Biosciences sector is Healthcare.
Artelo Biosciences ARTL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25788.43 USD — |
+0.79
|
6.39B USD — | 25545.71 USD — | 25840.56 USD — | — - | 6.39B USD — |
|
US Tech Capital Market Composite
RCMP
US
|
145.55 USD — |
-0.67
|
— — | 143.97 USD — | 146.35 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1208.1 USD — |
+1.98
|
— — | 1192.12 USD — | 1210.64 USD — | — - | — — |
- {{ link.label }} {{link}}